TGFβ signaling regulates the choice between pluripotent and neural fates during reprogramming of human urine derived cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Lihui ^a,b,c   Li, Xirui ^a   Huang, Wenhao ^a   Zhou, Tiancheng ^a   Wang, Haitao ^a   Lin, Aiping ^a   Hutchins, Andrew Paul ^a   Su, Zhenghui ^a   Chen, Qianyu ^a   Pei, Duanqing ^a   Pan, Guangjin ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; CYTOLOGY; FEMALE; HUMAN; INDUCED PLURIPOTENT STEM CELL; MALE; METABOLISM; NEURAL STEM CELL; NUCLEAR REPROGRAMMING; SIGNAL TRANSDUCTION; URINE;

CELLS, CULTURED; CELLULAR REPROGRAMMING; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; NEURAL STEM CELLS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; URINE;

EID: 84960194023     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22484     Document Type: Article

References (32)

1. Aboody, K., Capela, A., Niazi, N., Stern, J. H. & Temple, S. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone. Neuron 70, 597-613 (2011).
2. Lindvall, O. & Kokaia, Z. Stem cell research in stroke: how far from the clinic? Stroke 42, 2369-2375 (2011).
3. Breunig, J. J., Haydar, T. F. & Rakic, P. Neural stem cells: historical perspective and future prospects. Neuron 70, 614-625 (2011).
4. Takahashi, K. et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131, 861-872 (2007).
5. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
6. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
7. Soldner, F. et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318-331 (2011).
8. Israel, M. A. et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482, 216-220 (2012).
9. Han, D. W. et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell stem cell 10, 465-472 (2012).
10. Ring, K. L. et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11, 100-109 (2012).
11. Thier, M. et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell stem cell 10, 473-479 (2012).
12. Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
13. Pang, Z. P. et al. Induction of human neuronal cells by defined transcription factors. Nature 476, 220-223 (2011).
14. Caiazzo, M. et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476, 224-227 (2011).
15. Yoo, A. S. et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476, 228-231 (2011).
16. Son, E. Y. et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell stem cell 9, 205-218 (2011).
17. Wang, L. et al. Generation of integration-free neural progenitor cells from cells in human urine. Nature methods 10, 84-89 (2013).
18. Maherali, N. & Hochedlinger, K. Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Current biology : CB 19, 1718-1723 (2009).
19. Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell stem cell 7, 51-63 (2010).
20. Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8, 424-429 (2011).
21. Lin, T. et al. A chemical platform for improved induction of human iPSCs. Nature methods 6, 805-808 (2009).
22. Samavarchi-Tehrani, P. et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell stem cell 7, 64-77 (2010).
23. Polo, J. M. & Hochedlinger, K. When fibroblasts MET iPSCs. Cell stem cell 7, 5-6 (2010).
24. Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3, 807-821 (2003).
25. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
26. Brons, I. G. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195 (2007).
27. Kashyap, V. et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18, 1093-1108 (2009).
28. James, D., Levine, A. J., Besser, D. & Hemmati-Brivanlou, A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282 (2005).
29. Gingold, J. A. et al. A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming. Mol Cell 56, 140-152 (2014).
30. Maza, I. et al. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Nature biotechnology 33, 769-774 (2015).
31. Bar-Nur, O. et al. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nature biotechnology 33, 761-768 (2015).
32. Zhou, T. et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7, 2080-2089 (2012).